0001666071-21-000088.txt : 20210511
0001666071-21-000088.hdr.sgml : 20210511
20210511183224
ACCESSION NUMBER: 0001666071-21-000088
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20210507
FILED AS OF DATE: 20210511
DATE AS OF CHANGE: 20210511
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Christiansen Andrew
CENTRAL INDEX KEY: 0001805400
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-38386
FILM NUMBER: 21912864
MAIL ADDRESS:
STREET 1: C/O CARDLYTICS, INC.
STREET 2: 675 PONCE DE LEON AVENUE NE, SUITE 6000
CITY: ATLANTA
STATE: GA
ZIP: 30308
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: Cardlytics, Inc.
CENTRAL INDEX KEY: 0001666071
STANDARD INDUSTRIAL CLASSIFICATION: SERVICES-COMPUTER PROGRAMMING, DATA PROCESSING, ETC. [7370]
IRS NUMBER: 263039436
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 675 PONCE DE LEON AVENUE, NE
STREET 2: SUITE 6000
CITY: ATLANTA
STATE: GA
ZIP: 30308
BUSINESS PHONE: 888-798-5802
MAIL ADDRESS:
STREET 1: 675 PONCE DE LEON AVENUE, NE
STREET 2: SUITE 6000
CITY: ATLANTA
STATE: GA
ZIP: 30308
4
1
wf-form4_162077232536742.xml
FORM 4
X0306
4
2021-05-07
0
0001666071
Cardlytics, Inc.
CDLX
0001805400
Christiansen Andrew
C/O CARDLYTICS, INC.
675 PONCE DE LEON AVENUE NE, SUITE 6000
ATLANTA
GA
30308
0
1
0
0
Chief Financial Officer
Common Stock
2021-05-07
4
S
0
287
99.93
D
15560
D
Common Stock
2021-05-07
4
S
0
1000
100.98
D
14560
D
Common Stock
2021-05-07
4
S
0
850
102.25
D
13710
D
Common Stock
2021-05-07
4
S
0
550
103.46
D
13160
D
Common Stock
2021-05-07
4
S
0
204
104.02
D
12956
D
Common Stock
2021-05-07
4
S
0
50
105.15
D
12906
D
Common Stock
2021-05-10
4
S
0
250
98.25
D
12656
D
Shares sold to satisfy withholding tax obligations upon the delivery of shares of common stock for RSUs that vested on April 1, 2021.
The price reported is a weighted average sales price. These shares were sold in multiple transactions at prices ranging from $99.59 to $100.24, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in footnote (2), (3), (4), (5) and (6) to this Form 4.
The price reported is a weighted average sales price. These shares were sold in multiple transactions at prices ranging from $100.61 to $101.55, inclusive.
The price reported is a weighted average sales price. These shares were sold in multiple transactions at prices ranging from $101.93 to $102.83, inclusive.
The price reported is a weighted average sales price. These shares were sold in multiple transactions at prices ranging from $102.99 to $103.98, inclusive.
The price reported is a weighted average sales price. These shares were sold in multiple transactions at prices ranging from $104.01 to $104.06, inclusive.
These transactions were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on November 13, 2020.
/s/ Kirk L. Somers, Attorney-in-Fact
2021-05-11